Clinical trial
Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil
NCT00068692 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 15, 2003
- Completion date
- November 15, 2016
- Enrollment
- 225 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal mucinous adenocarcinoma, rectal signet ring cell adenocarcinoma, recurrent rectal carcinoma, stage iia rectal cancer ajcc v7, stage iib rectal cancer ajcc v7, stage iic rectal cancer ajcc v7, stage iiia rectal cancer ajcc v7, stage iiib rectal cancer ajcc v7, stage iiic rectal cancer ajcc v7, stage iva rectal cancer ajcc v7, stage ivb rectal cancer ajcc v7